Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells

British Journal of Cancer

Volumn 77, Issue 4, 1998, Pages 567-572

  Harada, N ^a   Hatano, O ^b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Aromatase inhibitors; Choriocarcinoma cell; Hepatoma cell; Oestrogen synthetase; Suicide substrate

Indexed keywords

AROMATASE; AROMATASE INHIBITOR; ATAMESTANE; CYCLOHEXIMIDE; FADROZOLE; FORMESTANE; FORSKOLIN; MESSENGER RNA; PENTETRAZOLE; SUICIDE SUBSTRATE; VOROZOLE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME STABILITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL;

EID: 0031975675     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.92     Document Type: Article

References (38)

1. Abul-Hajj YJ, Iverson R and Kiang DT (1979) Aromatization of androgens by human breast cancer. Steroids 33: 205-222
2. Amarneh B, Corbin CJ, Peterson JA, Simpson ER and Graham LS (1993) Functional domains of human aromatase cytochrome P450 characterized by linear alignment and site-directed mutagenesis. Mol Endocrinol 7: 1617-1624
3. Brodie AM (1994) Aromatase inhibitors in the treatment of breast cancer. J Steroid Biochem Mol Biol 49: 281-287
4. Brodie AMH, Garrett W, Hendrickson JR, Tsai-Morris C-H, Marcotte CH and Robinson CH (1981) Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-diono and sustained effects in vivo. Steroids 38: 693-702
5. Bulun SE, Price TM, Aitken J, Mahendroo MS and Simpson ER (1993) A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab 77: 1622-1628
6. Chen S and Zhou D (1992) Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments. J Biol Chem 267: 22587-22594
7. Esteban JM, Warsi Z, Haniu M, Hall P, Shively JE and Chen S (1992) Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation. Am J Pathol 140: 337-343
8. Foidart A, Harada N and Balthazart J (1994) Effects of steroidal and non steroidal aromatase inhibitors on sexual behavior and aromatase-immunoreactive cells and fibers in the quail brain. Brain Res 657: 105-123
9. Graham-Lorence S, Khalil MW, Lorence MC, Mendelson CR and Simpson ER (1991) Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis. J Biol Chem 266: 11939-11946
10. Graham-Lorence S, Amarneh B, White RE, Peterson JA and Simpson ER (1995) A three-dimensional model of aromatase cytochrome P450. Protein Sci 4: 1065-1080
11. Harada N (1988) Novel properties of human placental aromatase as cytochrome P-450: purification and characterization of a unique form of aromatase. J Biochem 103: 106-113
12. Harada N and Omura T (1980) Participation of cytochrome P-450 in the reduction of nitro compounds by rat liver microsomes. J Biochem 87: 1539-1554
13. Harada N and Omura T (1983) Phenobarbital- and 3 methylcholanthrene-induced synthesis of two different molecular species of microsomal cytochrome P-450 in rat liver. J Biochem 93: 1361-1373
14. Harada N, Utsumi T and Takagi Y (1995) Molecular and epidemiological analyses of abnormal expression of aromatase in breast cancer. Pharmacogenetics 5: 59-64
15. Hatano O, Takayama K, Imai T, Waterman MR, Takakusu A, Omura T and Morohashi K (1994) Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development 120: 2787-2797
16. Henderson D, Norbisrath G and Kerb U (1986) 1-Methyl-1, 4-androstadiene-3,17-dione (SH 489): Characterization of an irreversible inhibitor of estrogen biosynthesis. J Steroid Biochem Mol Biol 24: 303-306
17. Kitawaki J, Yoshida N and Osawa Y (1989) An enzyme-linked immunosorbent assay for quantitation of aromatase cytochrome P-450. Endocrinology 124: 1417-1423
18. Lu Q, Nakmura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G and Brodie A (1996) Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 137: 3061-3068
19. Marsh DA, Brodie HJ, Garrett WM, Tsai-Morris CH and Brodie AMH (1985) Aromatase inhibitors - synthesis and biological activity of androstenedione derivatives. J Med Chem 28: 788-795
20. Miller WR and Mullen P (1993) Factors influencing aromatase activity in the breast. J Steroid Biochem Mol Biol 44: 597-604
21. Miller WR and O'Neill J (1987) The importance of local synthesis of estrogen within the breast. Steroids 50: 537-548
22. Naganuma H, Ohtani H, Harada N and Nagura H (1990) Immunoelectron microscopic localization of aromatase in human placenta and ovary using microwave fixation. J Histochem Cytochem 38: 1427-1432
23. Noble LS, Simpson ER, Johns A and Bulun SK (1996) Aromatase expression in endometriosis. J Clin Endocrinol Metab 81: 174-179
24. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. J Biol Chem 239: 2379-2385
25. Poulos TL, Finzel BC, Gunsalus IC, Wagner GC and Kraut J (1985) The 2.6 A crystal structure of Pseudomonas putida cytochrome P-450. J Biol Chem 260: 16122-16130
26. Ravichandran KG, Boodupalli SS, Haseman CA, Peterson JA and Deisenhofer J (1993) Crystal structure of hemoprotein domain of P450BM-3, a prototype of microsomal P450s. Science 261: 731-736
27. Santen RJ and Misbin RI (1981) Aminoglutethimide: review of pharmacology and clinical uses. Pharmacotherapy 1: 95-120
28. Santen RJ, Martel J, Hoagland M, Naftolin F, Roa L, Harada N, Hafer L, Zaino R and Santner SJ (1994) Stromal spindle cells contain aromatase in human breast tumors. J Clin Endocrinol Metab 79: 627-632
29. Santner SJ, Feil PD and Santen RJ (1984) In situ estrogen production via the estrogen sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J Clin Endocrinol Metab 59: 29-33
30. Sasano H, Nagura H, Harada N, Goukon Y and Kimura M (1994) Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25: 530-535
31. Schimke RT (1964) The importance of both synthesis and degradation in the control of arginase levels in rat liver. J Biol Chem 239: 3808-3817
32. Schimke RT, Sweeney EW and Berlin CM (1965) The roles of synthesis and degradation in the control of rat liver tryptophan pyrrolase. J Biol Chem 240: 322-331
33. Steele RE, Mellor LB, Sawyer WK, Wasvary JM and Brown RE (1987) In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS16949A. Steroids 50: 147-161
34. Takemori S, Sato H, Gomi T, Suhara K and Kalagiri M (1975) Purification and properties of cytochrome P-450 11β from adrenocortical mitochondria. Biochem Biophys Res Commun 67: 1151-1157
35. Tan J and Muto N (1986) Purification and reconstitution properties of human placental aromatase: a cytochrome P-450-type monooxygenase. Eur J Biochem 156: 243-250
36. Utsumi T, Harada N, Maruta M and Takagi Y (1996) Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. J Clin Endocrinol Metab 81: 2344-2349
37. Vanden Bossche H, Willemsens G, Roels I, Bellens D, Moereels H, Coene MC, LeJeune L, Lauwers W and Janssen PAJ (1990) R76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent estrogen synthesis. Biochem Pharmacol 40: 1707-1718
38. Zhou DJ, Pompon D and Chen SA (1991) Structure-function studies of human aromatase by site directed mutagenesis: kinetic properties of mutants Pro-308-Phe, Tyr-361-Phe, Tyr-361-Leu, and Phe-406-Arg. Proc Natl Acad Sci USA 88: 410-414